Promimic Investor Relations Material

Promimic AB is a Sweden-based biomaterial company specializing in the development, manufacture, and sale of innovative biomaterials designed to enhance osseointegration, or bone healing. Their core technology revolves around a unique, nano-thin surface treatment, which is applied to various implant materials to improve bone integration. .Promimic's products find their applications primarily in the orthopedic and dental implant markets, aiming to improve patient outcomes through enhanced healing processes. The company's innovative approach to biomaterials positions it as a key player in the medical implant industry, providing solutions that cater to the increasing demand for advanced osseointegration technologies. The company is headquartered in Mölndal, Sweden, and its shares are listed on the Nasdaq First North Growth Market.